Legal & Regulatory
Global Legal Status Map
Regulatory status across 20 key countries based on publicly available guidance and community research — always verify with local authorities. Not legal advice.
Legal / Approved0
Gray area / Unscheduled18
Banned / Controlled2
Legal / Approved
Gray area / Unscheduled
Banned / Controlled
No data
Hover a country for its status
Breakdown
BPC-157 — by country
| Country | Status | Classification |
|---|---|---|
| Brazil | Gray | Gray area / Unscheduled |
| Canada | Gray | Gray area / Unscheduled |
| China | Gray | Gray area / Unscheduled |
| France | Gray | Gray area / Unscheduled |
| Germany | Gray | Gray area / Unscheduled |
| India | Gray | Gray area / Unscheduled |
| Italy | Gray | Gray area / Unscheduled |
| Japan | Gray | Gray area / Unscheduled |
| Mexico | Gray | Gray area / Unscheduled |
| Netherlands | Gray | Gray area / Unscheduled |
| Russia | Gray | Gray area / Unscheduled |
| South Africa | Gray | Gray area / Unscheduled |
| South Korea | Gray | Gray area / Unscheduled |
| Spain | Gray | Gray area / Unscheduled |
| Sweden | Gray | Gray area / Unscheduled |
| UAE | Gray | Gray area / Unscheduled |
| United Kingdom | Gray | Gray area / Unscheduled |
| United States | Gray | Gray area / Unscheduled |
| Australia | Banned | Banned / Controlled |
| New Zealand | Banned | Banned / Controlled |
This data reflects publicly available regulatory information and community research as of 2025. Regulatory status can change — always consult local health authorities or legal counsel before importing or using any peptide. This is not legal advice.